Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Invivoscribe, Inc.Updated: May 4, 2025Locations: 1
Eligibility criteria

Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and... [+1]

Sample/specimen has been obtained from a third-party vendor with a Materials Tra... [+1]

Status: Not yet recruiting

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

This protocol describes the pivotal accuracy study for the IdentiClone Dx TRG Assay. The intent of the accuracy study is to demonstrate agreement between the results of the IC TRG Dx Assay and a predicate devise or assay on retrospective and residual de-identified DNA extracted from FFPE (Formalin Fixed Paraffin Embedded) samples from individuals with suspected T-Cell Lymphoproliferations. The predicate device will be the LymphoTrack Dx TRG (FR1/FR2/FR3) Assays - MiSeq (LT Dx TRG-CE-IVD), which is a CE-IVD assay with a similar intended use as the IC TRG Assay on the same sample type.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Invivoscribe, Inc.Updated: Mar 14, 2025Locations: 3
Eligibility criteria

De-identified, residual FFPE specimens with a minimum of 8 curls [+5]